Carter Bankshares (CARE) Cash & Equivalents (2020 - 2022)

Carter Bankshares' Cash & Equivalents history runs 3 years deep, the most recent figure standing at $65.7 million for Q3 2022.

• Quarterly Cash & Equivalents fell 70.9% year-over-year to $65.7 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $65.7 million (down 70.9% YoY) and the FY2021 annual result came in at $277.8 million, up 14.82% from the prior year.
• Cash & Equivalents was $65.7 million for Q3 2022 at Carter Bankshares, down from $70.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $277.8 million in Q4 2021 and bottomed at $65.7 million in Q3 2022.
• A 3-year average of $178.2 million and a median of $217.9 million in 2021 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2021 — Cash & Equivalents climbed 14.82% — and 2022, when it sank 70.9%.
• Carter Bankshares' Cash & Equivalents stood at $241.9 million in 2020, then gained by 14.82% to $277.8 million in 2021, then slumped by 76.35% to $65.7 million in 2022.
• Business Quant data shows CARE's Cash & Equivalents at $65.7 million in Q3 2022, $70.2 million in Q2 2022, and $108.0 million in Q1 2022.